Amgen discovers, develops, manufactures and delivers human therapeutics for patients suffering from serious illnesses.
Read moreAnnual Revenue
$26.3B
Amgen's revenue is the ranked 15th among it's top 10 competitors. The top 10 competitors average 34.7B. Over the last four quarters, Amgen's revenue has decreased by 4.4%. Specifically, in Q1 2022's revenue was $6.2B; in Q4 2021, it was $6.8B; in Q3 2021, it was $6.7B; in Q2 2021, Amgen's revenue was $6.5B.